Back

Apolipoprotein C-III inhibition to lower triglycerides: one ring to rule them all?

European Heart Journal

17 February 2022
Organised by: Logo
Read full article
ESC Journals PREVENTIVE CARDIOLOGY Risk Factors and Prevention BASIC SCIENCE

Contributors

Robert A. Hegele
Robert A. Hegele

Author

Western University London , Canada

You may be interested in
thumbnail
Congress Presentation
RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency
31 August 2020
thumbnail
Congress Presentation
Cardiovascular risk reduction & hypertriglyceridemia: integrating the evidence
29 August 2025
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Congress Presentation
Association of dynamic changes in triglyceride-glucose index with lipid profiles and target attainments in coronary artery disease patients undergoing lipid-lowering therapy
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources